{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T05:46:46Z","timestamp":1771652806950,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.rdc.2010.05.002","type":"journal-article","created":{"date-parts":[[2010,8,4]],"date-time":"2010-08-04T05:15:04Z","timestamp":1280898904000},"page":"559-572","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Pauci-Immune Necrotizing Glomerulonephritis"],"prefix":"10.1016","volume":"36","author":[{"given":"Abraham","family":"Rutgers","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan S.F.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen A.","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cees G.M.","family":"Kallenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2010.05.002_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2010.05.002_bib2","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1002\/art.23800","article-title":"Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts","volume":"58","author":"Pagnoux","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.002_bib3","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2006.01.026","article-title":"Renal involvement in Churg-Strauss syndrome","volume":"47","author":"Sinico","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.rdc.2010.05.002_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0272-6386(12)80521-X","article-title":"Antineutrophil cytoplasmic autoantibodies and associated diseases: a review","volume":"15","author":"Jennette","year":"1990","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.002_bib5","first-page":"921","article-title":"Anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and vasculitis","volume":"135","author":"Jennette","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1016\/j.rdc.2010.05.002_bib6","first-page":"36","article-title":"Uber die eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems unde der nieren","volume":"102","author":"Wegener","year":"1939","journal-title":"Beitrage zur Path Anat"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.002_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ajkd.2005.05.003","article-title":"Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis","volume":"46","author":"Rutgers","year":"2005","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.rdc.2010.05.002_bib8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1046\/j.1523-1755.2002.00089.x","article-title":"Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups","volume":"61","author":"Hauer","year":"2002","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.rdc.2010.05.002_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1681\/ASN.V7123","article-title":"Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis","volume":"7","author":"Hogan","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.rdc.2010.05.002_bib10","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1681\/ASN.2005080870","article-title":"Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement","volume":"17","author":"de Lind van Wijngaarden","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.rdc.2010.05.002_bib11","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1111\/j.1523-1755.2004.00632.x","article-title":"Immune complex deposits in ANCA-associated crescentic glomerulonephritis: a study of 126 cases","volume":"65","author":"Haas","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib12","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/j.1523-1755.2004.00853.x","article-title":"Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies","volume":"66","author":"Holmen","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib13","first-page":"224","article-title":"Disease patterns in vasculitis \u2013 still a mystery","volume":"66","author":"Hoffman","year":"2008","journal-title":"Bull NYU Hosp Jt Dis"},{"issue":"3\u20134","key":"10.1016\/j.rdc.2010.05.002_bib14","first-page":"275","article-title":"Determinants of vessel targeting in vasculitis","volume":"11","author":"Hoffman","year":"2004","journal-title":"Clin Dev Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2010.05.002_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1440-1797.2008.01068.x","article-title":"Autoantibodies against glomerular endothelial cells in anti-neutrophil cytoplasmic autoantibody-associated systemic vasculitis","volume":"14","author":"Hu","year":"2009","journal-title":"Nephrology (Carlton)"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/MNH.0b013e3283296044","article-title":"Update on the glomerular filtration barrier","volume":"18","author":"Jarad","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1016\/j.rdc.2010.05.002_bib17","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s00467-004-1522-0","article-title":"Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcal glomerulonephritis","volume":"19","author":"Besbas","year":"2004","journal-title":"Pediatr Nephrol"},{"issue":"11","key":"10.1016\/j.rdc.2010.05.002_bib18","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/ndt\/gfh487","article-title":"Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis","volume":"19","author":"Tam","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.rdc.2010.05.002_bib19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1523-1755.2005.00063.x","article-title":"ANCA-induced neutrophil F-actin polymerization: implications for microvascular inflammation","volume":"67","author":"Tse","year":"2005","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.rdc.2010.05.002_bib20","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1093\/rheumatology\/kep304","article-title":"Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa","volume":"48","author":"Mohammad","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.rdc.2010.05.002_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/acr.20176","article-title":"The effects of duration of glucocorticoid therapy on relapse rate in anti-neutrophil cytoplasm antibody associated vasculitis: a meta-analysis","author":"Walsh","year":"2010","journal-title":"Arthritis Care Res"},{"issue":"10","key":"10.1016\/j.rdc.2010.05.002_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial","volume":"150","author":"de Groot","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.rdc.2010.05.002_bib24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1093\/ndt\/16.10.2018","article-title":"The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review","volume":"16","author":"de Groot","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.rdc.2010.05.002_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.7326\/0003-4819-152-1-201001050-00021","article-title":"Comment on pulse versus daily oral cyclophosphamide in ANCA-associated vasculitis","volume":"152","author":"Levine","year":"2010","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.rdc.2010.05.002_bib26","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/rheumatology\/kei272","article-title":"Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment","volume":"45","author":"Sanders","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2010.05.002_bib27","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1681\/ASN.2007010066","article-title":"Chances of renal recovery for dialysis-dependent ANCA-associated glomerulonephritis","volume":"18","author":"de Lind van Wijngaarden","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.rdc.2010.05.002_bib28","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.002_bib29","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/ndt\/16.5.953","article-title":"Renal histopathology and clinical course in 94 patients with Wegener's granulomatosis","volume":"16","author":"Aasarod","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ki.1998.36","article-title":"Diagnostic predictive value of ANCA serology","volume":"53","author":"Jennette","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib31","first-page":"125","article-title":"Progressive renal disease despite immunosuppressive therapy in a patient with Wegener s granulomatosis","volume":"66","author":"Klein","year":"2008","journal-title":"Neth J Med"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1046\/j.1523-1755.1998.00807.x","article-title":"Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC\/BCR Project for ANCA Assay Standardization","volume":"53","author":"Hagen","year":"1998","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.rdc.2010.05.002_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrneph.2009.67","article-title":"ANCA-negative pauci-immune crescentic glomerulonephritis","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"10.1016\/j.rdc.2010.05.002_bib34","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-143-9-200511010-00006","article-title":"Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome","volume":"143","author":"Sable-Fourtassou","year":"2005","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.rdc.2010.05.002_bib35","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/B:JOCI.0000029115.79266.ae","article-title":"ANCA-GBM dot-blot: evaluation of an assay in the differential diagnosis of patients presenting with rapidly progressive glomerulonephritis","volume":"24","author":"Rutgers","year":"2004","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.002_bib36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0953-6205(03)00097-9","article-title":"ANCA and anti-GBM antibodies in diagnosis and follow-up of vasculitic disease","volume":"14","author":"Rutgers","year":"2003","journal-title":"Eur J Intern Med"},{"issue":"8717","key":"10.1016\/j.rdc.2010.05.002_bib37","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/0140-6736(90)92205-V","article-title":"Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre","volume":"336","author":"Tervaert","year":"1990","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.rdc.2010.05.002_bib38","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O","article-title":"Prediction of relapses in Wegener's granulomatosis by measurement of antineutrophil cytoplasmic antibody levels: a prospective study","volume":"43","author":"Boomsma","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2010.05.002_bib39","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-147-9-200711060-00005","article-title":"Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis","volume":"147","author":"Finkielman","year":"2007","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.rdc.2010.05.002_bib40","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0272-6386(03)00025-8","article-title":"Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study","volume":"41","author":"Booth","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.002_bib41","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ndt\/gfg551","article-title":"Outcome in glomerulonephritis due to systemic small vessel vasculitis: effect of functional status and non-vasculitic co-morbidity","volume":"19","author":"Little","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.002_bib42","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1523-1755.2003.00769.x","article-title":"Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement","volume":"63","author":"Slot","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.rdc.2010.05.002_bib43","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1046\/j.1523-1755.1999.00666.x","article-title":"Recurrent ANCA-associated small vessel vasculitis after transplantation: a pooled analysis","volume":"56","author":"Nachman","year":"1999","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.rdc.2010.05.002_bib44","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1093\/ndt\/gfp347","article-title":"Renal transplantation in systemic vasculitis: when is it safe?","volume":"24","author":"Little","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.rdc.2010.05.002_bib45","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1681\/ASN.2007010090","article-title":"Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis","volume":"18","author":"Jayne","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib46","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.06010809","article-title":"Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement\u2013a prospective, open-label pilot trial","volume":"5","author":"Silva","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.rdc.2010.05.002_bib47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/qjmed\/93.7.433","article-title":"Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity","volume":"93","author":"Jayne","year":"2000","journal-title":"QJM"},{"issue":"5","key":"10.1016\/j.rdc.2010.05.002_bib48","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.7883\/yoken.JJID.2004.S17","article-title":"Intravenous immunoglobulin (IVIg) therapy in MPO-ANCA related polyangiitis with rapidly progressive glomerulonephritis in Japan","volume":"57","author":"Muso","year":"2004","journal-title":"Jpn J Infect Dis"},{"issue":"8","key":"10.1016\/j.rdc.2010.05.002_bib49","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/art.21142","article-title":"Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis","volume":"52","author":"de Groot","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2010.05.002_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.ASN.0000048716.42876.14","article-title":"15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy","volume":"14","author":"Birck","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.rdc.2010.05.002_bib51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/rheumatology\/kep411","article-title":"Long-term treatment of relapsing Wegener's granulomatosis with 15-deoxyspergualin","volume":"49","author":"Flossmann","year":"2010","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.rdc.2010.05.002_bib52","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1136\/ard.2008.092429","article-title":"Deoxyspergualin in relapsing and refractory Wegener's granulomatosis","volume":"68","author":"Flossmann","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2010.05.002_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X10000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:10:28Z","timestamp":1760181028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X10000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0889857X10000414"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2010.05.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pauci-Immune Necrotizing Glomerulonephritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2010.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}